Clinical Research Directory
Browse clinical research sites, groups, and studies.
Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study
Sponsor: Indiana University
Summary
This will be a multicenter registry-based study to evaluate safety and efficacy of GLP-1RA and SGLTi therapies in adjunct to insulin in adults with type 1 diabetes (T1D) over 1 year. This study will enroll participants who have been prescribed adjunct therapy as part of usual care.
Official title: Safety and Efficacy of Adjunct Therapies in Adults With Type 1diabetes: Multicenter, Registry Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
300
Start Date
2026-03-24
Completion Date
2028-04
Last Updated
2026-10-16
Healthy Volunteers
No
Conditions
Locations (17)
Hoag Memorial Hospital
Newport Beach, California, United States
University of California, San Francisco (UCSF)
San Francisco, California, United States
University of Miami
Miami, Florida, United States
Emory University
Atlanta, Georgia, United States
Northwestern University
Chicago, Illinois, United States
University of Louisville
Louisville, Kentucky, United States
Maine Health Research Institute
Portland, Maine, United States
Harvard Medical School
Boston, Massachusetts, United States
Henry Ford Hospital
Detroit, Michigan, United States
HealthPartners, International Diabetes Center
Minneapolis, Minnesota, United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
NYU Grossman School of Medicine
New York, New York, United States
Mount Sinai
New York, New York, United States
University of Rochester
Rochester, New York, United States
University of Cincinnati
Cincinnati, Ohio, United States
Ohio State University
Columbus, Ohio, United States
Eastern Virginia Medical Center, Old Dominion University
Norfolk, Virginia, United States